Australian Patent Journal Round-Up 25 October 2012

An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 25 October 2012.

If you wish to oppose the grant of a patent, or if grant of your own application has been opposed by third parties, please contact us.

Opposition Proceedings

Opposition Lodged

Acceptance of the following patent applications has been opposed as at 25 October 2012:

Application No. Applicant(s) Opponent(s)
2005322067 Polymer-von Willebrand factor-conjugates Baxter Healthcare SA; Baxter International Inc. William J Pickering.
2006240038 Materials and methods for respiratory disease control in canines Cornell Research Foundation, Inc.; University of Florida Research Foundation, Inc.; The Government of the United States of America As Represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention William J Pickering.
2009278275 Method for producing microlenses Giesecke & Devrient GmbH Securency International Pty Ltd
2010214641 Compositions and methods for the systemic treatment of arthritis Baylor Research Institute Shelford Services Pty Limited

Opposition Withdrawn

Opposition to acceptance of the following applications has been withdrawn, and the application shall proceed to sealing:

Application No. Applicant(s) Opponent(s)
2004266076 Pharmaceutical product for injection Nycomed GmbH Sandoz Pty Ltd
2007203451 Pharmaceutical composition containing a crystalline form of perindopril tert-butylamine salt Les Laboratoires Servier Apotex Pty Ltd
2009295253 A surgical orientation system and associated method Inertial Orthopaedic Navigation Solutions Pty Ltd KCAT Investments Pty Limited
2010341423 Method and system for managing customer relationships BNC Ventures B.V. Susan Matthews.


Opposition Dismissed

No opposition proceedings have been dismissed.


Applications Withdrawn

No applications have been withdrawn following opposition.


Extensions of Term of Standard Patents

Applications Filed

No applications for Extension of Term under Section 70 have been made.


Applications Accepted

The following application for Extension of Term has been accepted under Section 75:

Patent No. Patentee(s) Goods & First Reg. Approval
2007240156 Peptidomimetic protease inhibitors Vertex Pharmaceuticals Incorporated INCIVO telaprevir, 6 March 2012

Extensions granted

The following application(s) for Extension of Term have been granted under Section 76:

Patent No. Patentee(s) Goods & First Reg. Approval Extension of Term expiry, pursuant to Section 77
2001263466 Soluble CTLA4 mutant molecules and uses thereof Bristol-Myers Squibb Company NULOJIX belatacept (rch), 15 Mar 2012 23 May 2026
2002305758 Pharmaceutical compositions for the coordinates delivery of NSAIDs Pozen Inc VIMOVO naproxen and esomeprazole, 25 Oct 2011 25 Oct 2026
2010200249 Combines vaccines comprising hepatitis B surface antigen and other antigens SmithKline Beecham Biologicals (s.a.) INFANRIX PENTA infanrix penta, 07 Nov 2001 15 May 2013

Surrendered and Revoked Letters Patent

Surrendered Letters Patent

No patents have been offered for surrender.


Revocation of Letters Patent

No other patents have been wholly or partially revoked.